A securities class action has been filed against Beta Bionics (BBNX) alleging the company misled investors about FDA compliance for its iLet insulin delivery system. The class period runs July 30, 2025 to February 24, 2026. Lead plaintiff deadline is November 3, 2026.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
